More than half a billion people worldwide are living with diabetes, the vast majority with type 2 diabetes (T2D), a chronic condition that continues to rise alongside aging populations and changing lifestyles. Despite its prevalence, the cell-type-specific mechanisms that shape beta-cell adaptation and failure over time have remained only partially understood.
A new study led by researchers from VIB and KU Leuven shows that Parkinson’s disease can be divided into distinct subtypes, helping explain why a single treatment does not work for all patients. Using a machine-learning-driven analysis, the team identified two main groups and five subgroups of the disease, marking an important step toward more personalized therapies. The findings are published in Nature Communications.
ADDISON, Texas, May 5, 2026 /PRNewswire/ — FX Shoulder Solutions, Inc. has received FDA 510(k) clearance for the FX V135® Easytech Shoulder System, the next generation of stemless shoulder arthroplasty implants that provides surgeons with an anatomic stemless versus a modular stemmed-reverse option. This design enables surgeons to begin with a stemless approach and, when clinically appropriate, transition intraoperatively to a short stem solution without changing or adding another system.
Laidlaw Scholar Nikita Bhat has studied a new way to influence metabolic signaling with greater precision
Medtronic (NYSE:MDT) announced today that it received CE mark approval for its VitalFlow Transport Frame Air and Ground (AG) accessory.